who was the second?
He is an American physician and business executive, who was president and chief executive officer and chairman of the American pharmaceutical company Merck & Co.
P. Roy Vagelos
Pindaros Roy Vagelos (born October 8, 1929, in Westfield, New Jersey), better known as P. Roy Vagelos or Roy Vagelos, is an American physician and business executive, who was president and chief executive officer (1985) and chairman (1986) of the American pharmaceutical company Merck & Co. (known as MSD outside the U.S.).
what breed is the dog on the cesar commercial UNANSWERABLE what is it? It is a breed of dog from Scotland. how does it look? They have deep chest, muscular limbs, a black nose, and a short, closely fitted jaw with "scissors" bite. any illness that it can be affected with? Abdominal hernias, craniomandibular osteopathy, atopic dermatitis, lichenification, and hair loss. name few signs of the last disease? Hair loss in patches usually in circular patterns, baldness, dandruff, skin lesions, and scarring. name few medicines related to this disease? Minoxidil, finasteride, and dutasteride. what is the former ? It is a medication used for the treatment of high blood pressure and male-pattern hair loss. mention few negative effects of the same? Swelling of the face and extremities, rapid and irregular heartbeat, lightheadedness, cardiac lesions. name few names of trade? Alomax, Alopek, Recrea, Unipexil, Vaxdil to name a few. name few names of brand of the second medicine? Propecia, Proscar. name few historic personalities associated with this medicine? James Hamilton and  P. Roy Vagelos were involved in the research and observation of this drug reactions.
wiki:4378431
P. Roy Vagelos [SEP] Introduction
Pindaros Roy Vagelos (born October 8, 1929, in Westfield, New Jersey), better known as P. Roy Vagelos or Roy Vagelos, is an American physician and business executive, who was president and chief executive officer (1985) and chairman (1986) of the American pharmaceutical company Merck & Co. (known as MSD outside the U.S.). Since 1995, Vagelos has served as chairman of the board of Regeneron Pharmaceuticals. He was founding chair of the Prix Galien USA awards committee (from 2007-2017) and was the first recipient of the Galien Foundation's Pro Bono Humanum Award, which in 2018 was renamed in his honor to the Roy Vagelos Pro Bono Humanum Award for Global Health Equity.